Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,543 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of muscle mass loss assessed by computed tomography on the outcome of allogeneic stem cell transplantation.
Nagayama T, Fujiwara SI, Kikuchi T, Onda K, Murahashi R, Nakashima H, Ikeda T, Matsuoka S, Kawaguchi SI, Toda Y, Ito S, Ban T, Umino K, Minakata D, Nakano H, Yamasaki R, Morita K, Ashizawa M, Yamamoto C, Hatano K, Sato K, Oh I, Ohmine K, Kanda Y. Nagayama T, et al. Among authors: oh i. Leuk Lymphoma. 2022 Jul;63(7):1694-1700. doi: 10.1080/10428194.2022.2034159. Epub 2022 Feb 14. Leuk Lymphoma. 2022. PMID: 35156892
Pleocytosis after hemopoietic stem cell transplantation.
Nagashima T, Muroi K, Kawano-Yamamoto C, Miyoshi T, Tatara R, Meguro A, Fujiwara S, Obara Y, Oh I, Kikuchi S, Sato K, Matsuyama T, Toshima M, Ohmine K, Ozaki K, Takatoku M, Mori M, Nagai T, Ozawa K. Nagashima T, et al. Among authors: oh i. Leuk Lymphoma. 2006 Aug;47(8):1613-7. doi: 10.1080/10428190600625836. Leuk Lymphoma. 2006. PMID: 16966274
Mechanisms of immunomodulation by mesenchymal stem cells.
Ozaki K, Sato K, Oh I, Meguro A, Tatara R, Muroi K, Ozawa K. Ozaki K, et al. Among authors: oh i. Int J Hematol. 2007 Jul;86(1):5-7. doi: 10.1532/IJH97.07003. Int J Hematol. 2007. PMID: 17675259 Review.
Evaluation of platelet transfusion thresholds in patients with acute myeloblastic leukemia receiving induction chemotherapy.
Oka S, Muroi K, Mori M, Matsuyama T, Fujiwara S, Oh I, Ono Y, Kikuchi S, Sato K, Ueda M, Toshima M, Ozaki K, Takatoku M, Nagai T, Ozawa K. Oka S, et al. Among authors: oh i. Intern Med. 2007;46(19):1669-70. doi: 10.2169/internalmedicine.46.0345. Epub 2007 Oct 1. Intern Med. 2007. PMID: 17917331 Free article. No abstract available.
Cell and gene therapy using mesenchymal stem cells (MSCs).
Ozawa K, Sato K, Oh I, Ozaki K, Uchibori R, Obara Y, Kikuchi Y, Ito T, Okada T, Urabe M, Mizukami H, Kume A. Ozawa K, et al. Among authors: oh i. J Autoimmun. 2008 May;30(3):121-7. doi: 10.1016/j.jaut.2007.12.008. Epub 2008 Jan 31. J Autoimmun. 2008. PMID: 18249090 Review.
Rituximab plus 70% cyclophosphamide, doxorubicin, vincristine and prednisone for Japanese patients with diffuse large B-cell lymphoma aged 70 years and older.
Meguro A, Ozaki K, Sato K, Oh I, Fujiwara S, Hosonuma R, Sasazaki M, Kikuchi Y, Hirata Y, Yamamoto C, Uesawa M, Kobayashi H, Matsu H, Okabe H, Uehara E, Nishikawa A, Tatara R, Hatano K, Yamamoto C, Matsuyama T, Toshima M, Ueda M, Ohmine K, Suzuki T, Mori M, Nagai T, Muroi K, Ozawa K. Meguro A, et al. Among authors: oh i. Leuk Lymphoma. 2012 Jan;53(1):43-9. doi: 10.3109/10428194.2011.600486. Epub 2011 Aug 24. Leuk Lymphoma. 2012. PMID: 21864040
1,543 results